Dynamic Collaborations for the Development of Immune Checkpoint Blockade Agents

We studied the overview of drug discovery and development to understand the recent trends and potential success factors of interorganizational collaboration by reviewing 1204 transactions performed until 2019 for 107 anticancer drugs approved by the US Food and Drug Administration (FDA) from 1999 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Djurian, Arisa, Makino, Tomohiro, Lim, Yeongjoo, Sengoku, Shintaro, Kodama, Kota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225058/
https://www.ncbi.nlm.nih.gov/pubmed/34073680
http://dx.doi.org/10.3390/jpm11060460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225058/
https://www.ncbi.nlm.nih.gov/pubmed/34073680
http://dx.doi.org/10.3390/jpm11060460

Ejemplares similares